R. Mathew et al., MODULATION BY ATRIAL-NATRIURETIC-FACTOR OF RECEPTOR-MEDIATED CYCLIC-AMP-DEPENDENT RESPONSES IN CANINE PULMONARY-ARTERY DURING HEART-FAILURE, British Journal of Pharmacology, 118(8), 1996, pp. 1886-1890
1 Pacing-induced congestive heart failure (CHF) in dogs is associated
with increased plasma levels of atrial natriuretic factor (ANF) and in
hibiton of receptor-mediated cyclic AMP-dependent relaxation in isolat
ed pulmonary arteries (PA). Since ANF is known to be negatively couple
d to adenylate cyclase, we studied cyclic AMP-mediated relaxation to i
soprenaline (Iso) and arachidonic acid (AA) in PA from control dogs (C
), dogs with pacing-induced CHF (CHF) and dogs with bilateral atrial a
ppendectomy and CHF (ATR APP + CHF). 2 In CHF, plasma ANF levels incre
ased from a baseline of 80 +/- 8 pg ml(-1) to 283 +/- 64 pg ml(-1) (P<
0.05), but the ATR APP + CHF group failed to show this increase (67 +/
- 7 pg ml(-1) vs 94 +/- 15 pg ml(-1), P=NS). Plasma ANF levels, howeve
r, did not influence myocardial dysfunction in CHF. 3 The relaxation o
f 49 +/- 5% to 1 mu M Iso in C was reduced to 23 +/- 4% in CHF (P<0.05
), but relaxation of 49 +/- 12% was observed in the ATR APP +/- CHF gr
oup (P=NS vs C). Relaxation responses to 10 mu M AA were as follows: 7
7 +/- 5% (C, n=8), 27 +/- 8% (CHF, n=10, P<0.05 vs C), and 93 +/- 5% (
ATR APP + CHF, n=5). The presence of CHF, or the plasma ANF levels, di
d not affect responses to cyclic GMP-mediated relaxing agents in PA. 4
These data indicate that the myocardial performance in CHF is not inf
luenced by plasma ANF levels. However, altered cyclic AMP-mediated rel
axation in PA during CHF is, in part, modulated by circulating ANF lev
els.